Percent free prostate-specific antigen is effective to predict prostate biopsy outcome in Chinese men with prostate-specific antigen between 10.1 and 20.0 ng ml−1-Reference-Cited by-同舟云学术

Percent free prostate-specific antigen is effective to predict prostate biopsy outcome in Chinese men with prostate-specific antigen between 10.1 and 20.0 ng ml−1

Published:2015 Issue:6 Volume:17 Page:1017
ISSN:1008-682X
Container-title:Asian Journal of Andrology
language:en
Short-container-title:Asian J Androl

Author:

Sun Ying-Hao,Chen Rui,Zhou Li-Qun,Cai Xiao-Bing,Xie Li-Ping,Huang Yi-Ran,He Da-Lin,Gao Xu,Xu Chuan-Liang,Ding Qiang,Wei Qiang,Yin Chang-Jun,Ren Shan-Cheng,Wang Fu-Bo,Tian Ye,Sun Zhong-Quan,Fu Qiang,Ma Lu-Lin,Zheng Jun-Hua,Ye Zhang-Qun,Ye Ding-Wei,Xu Dan-Feng,Hou Jian-Quan,Xu Ke-Xin,Yuan Jian-Lin,Gao Xin,Liu Chun-Xiao,Pan Tie-Jun,CPCC

Publisher

Medknow

Subject

Urology,General Medicine

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Integrative proteogenomic profiling of high-risk prostate cancer samples from Chinese patients indicates metabolic vulnerabilities and diagnostic biomarkers;Nature Cancer;2024-09-06

2. Prevalence of tumour-infiltrating CD103+ cells identifies therapeutic-sensitive prostate cancer with poor clinical outcome;British Journal of Cancer;2023-02-09

3. Combining clinical parameters and multiparametric magnetic resonance imaging to stratify biopsy-naïve men for an optimum diagnostic strategy with prostate-specific antigen 4 ng ml−1 to 10 ng ml−1;Asian Journal of Andrology;2022-12-20

4. Development and validation of a predictive model for diagnosing prostate cancer after transperineal prostate biopsy;Frontiers in Oncology;2022-12-01

5. Clinical research analysis based on prostate cancer screening diagnosis;Andrologia;2022-01-11